GHK-Cu: Frequently Asked Questions for Research Use
A research-oriented FAQ addressing common questions about GHK-Cu, including its identity, handling, solubility, and the scope of preclinical literature. For laboratory research use only.
GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) complexed with copper(II). It appears in the preclinical literature as a research reagent studied in cell-culture and animal models of wound repair, extracellular matrix remodeling, and antioxidant-related pathways. The following FAQ summarizes commonly asked questions for laboratory researchers. Nothing here is intended as medical or veterinary guidance, and no dosage, treatment, or clinical claim is made or implied.
What is GHK-Cu? GHK-Cu is the copper(II) complex of the naturally occurring tripeptide GHK. The peptide sequence is glycine-histidine-lysine, and the histidine imidazole nitrogen provides a principal copper-binding site. In research settings it is typically supplied as a lyophilized powder.
What is the difference between GHK and GHK-Cu? GHK refers to the free tripeptide, while GHK-Cu refers to the peptide-copper complex. Investigators should confirm which form is specified in a given protocol, because the presence of copper can influence observed readouts in cell-free and cell-based assays.
How is GHK-Cu typically handled in the laboratory? General good laboratory practice applies: store lyophilized material desiccated and protected from light, minimize repeated freeze-thaw cycles of reconstituted solutions, and prepare working aliquots under sterile conditions when required. Because copper ions can interact with buffers, chelators, and certain assay components, researchers should verify compatibility with their specific experimental system.
What solvents are used for reconstitution? In the published literature, GHK-Cu is commonly reconstituted in water or aqueous buffer. Solubility and stability can vary with pH, ionic strength, and the presence of chelating agents. Investigators should consult the supplier's certificate of analysis and their own validation data rather than relying on generalized statements.
What areas of research have involved GHK-Cu? Preclinical reports have explored GHK-Cu in contexts such as fibroblast and keratinocyte culture, collagen and glycosaminoglycan synthesis, matrix metalloproteinase activity, and oxidative-stress models. These are in vitro and animal findings; they do not establish safety or efficacy in humans.
Is GHK-Cu approved for human use? No. GHK-Cu is supplied for research use only. It is not a drug, cosmetic, or therapeutic product, and it should not be administered to humans or animals outside an approved research protocol.
What are common pitfalls in GHK-Cu experiments? Potential issues include copper contamination from labware or media, chelation by serum or buffer components, peptide degradation, and concentration-dependent effects that may not be linear. Appropriate vehicle controls and copper-only controls can help distinguish peptide-specific from copper-related effects.
How should results be reported? Reports should specify the peptide source, purity, counter-ion or copper content where known, reconstitution method, storage conditions, vehicle, and the exact assay conditions. Transparent reporting supports reproducibility and avoids overinterpretation of preliminary findings.
This FAQ is provided for informational purposes for laboratory professionals and does not constitute advice on human or veterinary use.